Streamlining Ethical Review

scientific article published on November 16, 2010

Streamlining Ethical Review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7326/0003-4819-153-10-201011160-00008
P953full work available at URLhttp://www.annals.org/cgi/content/abstract/153/10/655
https://europepmc.org/articles/pmc4714763?pdf=render
https://europepmc.org/articles/PMC4714763
https://doi.org/10.7326/0003-4819-153-10-201011160-00008
https://europepmc.org/articles/PMC4714763?pdf=render
P932PMC publication ID4714763
P698PubMed publication ID21079221

P2093author name stringJoseph Millum
Jerry Menikoff
P2860cites workEthical review of research involving human subjects: when and why is IRB review necessary?Q35156679
A survey of IRB process in 68 U.S. hospitalsQ35923692
Variability in the costs of institutional review board oversightQ36547107
Grinding to a halt: the effects of the increasing regulatory burden on research and quality improvement effortsQ37536032
The dysregulation of human subjects research.Q53169769
Institutional review boards: a crisis in confidenceQ73438221
Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. NoticeQ77203559
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectresearch ethicsQ1132684
ethical reviewQ56515249
ethical analysisQ98139384
P304page(s)655-657
P577publication date2010-11-01
2010-11-16
P1433published inAnnals of Internal MedicineQ564416
P1476titleStreamlining ethical review
Streamlining Ethical Review
P478volume153

Reverse relations

cites work (P2860)
Q38665110A Proposed Process for Reliably Updating the Common Rule
Q34020789A national strategy to develop pragmatic clinical trials infrastructure.
Q35856764Canada's new ethical guidelines for research with humans: a critique and comparison with the United States
Q30650486Data collection in cancer clinical trials: Too much of a good thing?
Q30403064Duration of viral shedding in hospitalized patients infected with pandemic H1N1
Q35265285Education Research and Human Subject Protection: Crossing the IRB Quagmire
Q93009895Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands
Q38074497Getting through ethics: the fit between research ethics board assessments and qualitative research
Q33645428HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Q35151775Increasing burden of institutional review in multicenter clinical trials of infertility: the Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies.
Q28079643Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy
Q37707019Navigating the institutional review board approval process in a multicenter observational critical care study
Q90744019Operational Characteristics of Institutional Review Boards (IRBs) in the United States
Q36801384RESEARCH ETHICS. Evidence gaps and ethical review of multicenter studies
Q27303838Research ethics committees in the regulation of clinical research: comparison of Finland to England, Canada, and the United States.
Q35201882The role of the clinical and translational science awards program in improving the quality and efficiency of clinical research
Q53838918Why Public Comments Matter: The Case of the National Institutes of Health Policy on Single Institutional Review Board Review of Multicenter Studies.

Search more.